Skip to main content
HR 3240 106th Congress House Health Commerce Drug adulteration Drug approvals Drug industry Drugs Foreign Trade and International Finance Government Operations and Politics Government paperwork Government publicity Import restrictions Imports Labeling Pharmacists

Drug Import Fairness Act of 1999

Introduced: November 5, 1999 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 106th Congress ended
It never became law before the 106th Congress (1999–2000) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 13 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 29, 2000
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H5426-5427)
Jun 29, 2000
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H5426-5427)
Jun 29, 2000
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jun 29, 2000
Motion to reconsider laid on the table Agreed to without objection.
Jun 28, 2000
Mr. Bilbray moved to suspend the rules and pass the bill.
Jun 28, 2000
DEBATE - The House proceeded with forty minutes of debate on H.R. 3240.
Jun 28, 2000
DEBATE - The House resumed debate on H.R. 3240.
Jun 28, 2000
Considered under suspension of the rules. (consideration: CR H5426-5434)
Apr 11, 2000
Sponsor introductory remarks on measure. (CR H2096-2097)
Feb 14, 2000
Sponsor introductory remarks on measure. (CR H360-361)
Nov 17, 1999
Referred to the Subcommittee on Health and Environment.
Nov 5, 1999
Referred to the House Committee on Commerce.
Nov 5, 1999
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service
Drug Import Fairness Act of 1999 - Amends the Federal Food, Drug, and Cosmetic Act (FDCA) to prohibit the Secretary of Health and Human Services, with regard to a drug being imported or offered for import, from sending a notice to a person suggesting that importing the drug is, or appears to be, in violation of the FDCA unless: (1) the Secretary determines the drug is adulterated, misbranded, in violation of FDCA provisions relating to new drugs, the drug is forbidden or restricted in sale in the producing or exporting country, importation by any person other than the manufacturer violates reimportation provisions, or the importation otherwise violates Federal law; (2) the notice does not specify any provision described in the provisions of this act relating to those determinations that is not applicable to the drug's importation; and (3) the notice states the underlying reasons for the determination.
What's happening now June 29, 2000

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Bill text 3 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 3
 Cosponsors 1
All 1 Republican 1
R
Wicker, Roger F.
Mississippi · May 4, 2000
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 3240: Drug Import Fairness Act of 1999. 106th Congress. Open America. https://openamerica.io/bill/106-HR-3240/
MLA
"H.R. 3240: Drug Import Fairness Act of 1999." 106th Congress, 2026, Open America, https://openamerica.io/bill/106-HR-3240/.
Bluebook (legal)
H.R. 3240, 106th Cong. (2026), https://openamerica.io/bill/106-HR-3240/.
Markdown link
[H.R. 3240: Drug Import Fairness Act of 1999](https://openamerica.io/bill/106-HR-3240/)
Report a problem